Sinopharm Group Co. Ltd (X2S) — Free Cash Flow Generation Index
Sinopharm Group Co. Ltd (X2S) has a Free Cash Flow Generation Index of 0.98x as of December 2022. Free cash flow of €51.45 Billion represents 1% of operating cash flow (€52.39 Billion). Explore Sinopharm Group Co. Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sinopharm Group Co. Ltd Free Cash Flow Generation Index (2013–2025)
Historical FCF Generation Index trend for Sinopharm Group Co. Ltd across 13 annual periods. For the full cash flow conversion analysis, see how efficiently does Sinopharm Group Co. Ltd generate cash.
Annual Free Cash Flow Generation for Sinopharm Group Co. Ltd (2013–2025)
Year-by-year Free Cash Flow Generation Index for Sinopharm Group Co. Ltd. Check cash flow reinvestment rate of Sinopharm Group Co. Ltd to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.89x | €12.52 Billion | €14.14 Billion | €1.62 Billion | ▲ +6.8% |
| 2024 | 0.83x | €9.58 Billion | €11.55 Billion | €1.97 Billion | ▼ -4.0% |
| 2023 | 0.86x | €14.84 Billion | €17.17 Billion | €2.34 Billion | ▼ -2.3% |
| 2022 | 0.88x | €18.55 Billion | €20.96 Billion | €2.13 Billion | ▼ -11.5% |
| 2021 | 1.00x | €9.31 Billion | €9.31 Billion | €2.07 Billion | ▲ +0.0% |
| 2020 | 1.00x | €11.15 Billion | €11.15 Billion | €1.90 Billion | ▲ +15.7% |
| 2019 | 0.86x | €16.23 Billion | €18.78 Billion | €2.21 Billion | ▲ +1165.0% |
| 2018 | 0.07x | €249.62 Million | €3.65 Billion | €3.24 Billion | ▲ +196.4% |
| 2017 | -0.07x | €-227.35 Million | €3.21 Billion | €2.12 Billion | ▼ -106.2% |
| 2016 | 1.15x | €10.62 Billion | €9.26 Billion | €1.36 Billion | ▲ +6.6% |
| 2015 | 1.08x | €14.43 Billion | €13.41 Billion | €1.02 Billion | ▼ -14.7% |
| 2014 | 1.26x | €7.01 Billion | €5.56 Billion | €1.45 Billion | ▲ +2.6% |
| 2013 | 1.23x | €6.07 Billion | €4.94 Billion | €1.13 Billion | — |